Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2015 | The Trials Acceleration Programme by Leukaemia & Lymphoma Research

Charles Craddock • 12 Jun 2015
EHA 2015
General

At the 20th Congress of the European Hematology Association (EHA), Charles Craddock, FRCPath, FRCP, DPhil, BMBCh, of the University of Birmingham, Birmingham, UK, discusses the Trials Acceleration Programme (TAP) initiative by Leukaemia & Lymphoma Research. TAP aims to accelerate the clinical development of new therapies for patients with blood cancer through the creation of a network of leading treatment centers around the UK.

More from Charles Craddock

Strategies to reduce relapse risk post-transplant in AML
11:48
Strategies to reduce relapse risk post-transplant in AML
Charles Craddock • 19 Sep 2026
Expanding donor access for allogeneic transplantation in AML
2:46
Expanding donor access for allogeneic transplantation in AML
Charles Craddock • 19 Sep 2026
Allogeneic transplantation in fit older adults with AML
1:34
Allogeneic transplantation in fit older adults with AML
Charles Craddock • 19 Sep 2026
Maximizing the graft-versus-leukemia effect after allogeneic transplantation in AML
1:35
Maximizing the graft-versus-leukemia effect after allogeneic transplantation in AML
Charles Craddock • 19 Sep 2026

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals